Company News: Positive clinical trial results or new product launches can drive the stock price up, while negative results or regulatory setbacks can push it down.

Market Sentiment: General investor optimism or pessimism towards the biotechnology sector can influence BIOT.ST stock, regardless of company-specific news.

Financial Performance: Strong revenue growth, profitability, and healthy cash flow often lead to a higher stock price. Conversely, losses or declining revenue can decrease it.

Regulatory Environment: Changes in regulations related to drug approvals or healthcare policies can impact the value of biotech companies like BIOT.ST.

Competition: The emergence of new competitors or superior products from existing rivals can negatively affect BIOT.ST's market share and stock price.

Economic Conditions: Overall economic growth or recession can influence investor risk appetite and the availability of capital for biotech investments, affecting BIOT.ST.

Interest Rates: Higher interest rates can make borrowing more expensive for biotech companies and reduce investor interest in growth stocks like BIOT.ST.

Technological Advancements: Breakthroughs in biotechnology or related fields can create opportunities or threats for BIOT.ST, impacting its stock value.